Sunnie Kim is an Oncology physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 60 publications with 313 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1665 Aurora Ct
Aurora, CO 800452517
Telephone
720-848-0000Provider last certified this registry record 3 Jul 2024.
Clinical trials
- Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
Sponsor: University of Colorado, Denver
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20257 payments$10,634openpaymentsdata.cms.gov ↗
- BeOne Medicines USA, Inc.Program year20258 payments$10,555openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202514 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
56.6%Opioid Agonist22.1%Oxycodone Hcl54%Morphine Sulfate Er26%Tramadol Hcl20%Part D<11 patientsPhenothiazine16%Prochlorperazine Maleate100%Part D≥24 patients+ 3 more classes in this area
Metabolism & gastrointestinal
26.6%Serotonin-3 Receptor Antagonist14.3%Ondansetron Hcl100%Part D≥25 patientsAntidiarrheal microorganisms6.1%Creon100%Part D<11 patients+ 1 more class in this area
Cardiovascular
10.2%Antiarrhythmic10.2%Lidocaine-Prilocaine100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacokinetics and pharmacodynamics of the GCN2 activator HC-7366 in a phase 1a study in patients with advanced solid tumors.
Journal of Clinical Oncology
2026 - <i>TP53</i> Y220C mutations in pancreatic ductal adenocarcinoma (PDAC): A genomic landscape study.
Journal of Clinical Oncology
2025 - Real-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal Cancer
Journal of the National Comprehensive Cancer Network
2025 - Immune Landscape of Epstein–Barr Virus–Associated Gastric Cancer: Analysis From a Western Academic Institution
Journal of Surgical Research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”